Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-004973
Filing Date
2022-06-09
Accepted
2022-06-09 16:56:29
Documents
2
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6286
2 POA UPDATED JUNE 2022 poa_aadams2022.txt EX-24 3473
  Complete submission text file 0001562180-22-004973.txt   11110
Mailing Address C/O AUXILIUM PHARMACEUTICALS, INC. 640 LEE ROAD CHESTERBROOK PA 19355
Business Address
ADAMS ADRIAN (Reporting) CIK: 0001248144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36352 | Film No.: 221006619

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations